aTyr Pharma (LIFE) Misses Q4 EPS by 1c

aTyr Pharma (NASDAQ: LIFE) reported Q4 EPS of ($0.25), $0.01 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
• Viking Holdings Ltd (VIK) Tops Q2 EPS by 36c